254 related articles for article (PubMed ID: 21981905)
1. Greasing the wheels of managing overweight and obesity with omega-3 fatty acids.
Golub N; Geba D; Mousa SA; Williams G; Block RC
Med Hypotheses; 2011 Dec; 77(6):1114-20. PubMed ID: 21981905
[TBL] [Abstract][Full Text] [Related]
2. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
4. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Abeywardena MY; Patten GS
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
[TBL] [Abstract][Full Text] [Related]
5. The effect of omega-3 fatty acid supplementation on weight loss and cognitive function in overweight or obese individuals on weight-loss diet.
Salman HB; Salman MA; Yildiz Akal E
Nutr Hosp; 2022 Aug; 39(4):803-813. PubMed ID: 35815739
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid biochemistry: perspectives from human nutrition.
Innis SM
Mil Med; 2014 Nov; 179(11 Suppl):82-7. PubMed ID: 25373090
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.
Doughman SD; Krupanidhi S; Sanjeevi CB
Curr Diabetes Rev; 2007 Aug; 3(3):198-203. PubMed ID: 18220672
[TBL] [Abstract][Full Text] [Related]
12. Microbial production of docosahexaenoic acid (DHA): biosynthetic pathways, physical parameter optimization, and health benefits.
Abbas N; Riaz S; Mazhar S; Essa R; Maryam M; Saleem Y; Syed Q; Perveen I; Bukhari B; Ashfaq S; Abidi SHI
Arch Microbiol; 2023 Aug; 205(9):321. PubMed ID: 37642791
[TBL] [Abstract][Full Text] [Related]
13. Consumption of Monounsaturated Fatty Acids Is Associated with Improved Cardiometabolic Outcomes in Four African-Origin Populations Spanning the Epidemiologic Transition.
Mehta S; Ruth Dugas L; Choo-Kang C; Bovet P; Forrester T; Bedu-Addo K; Lambert EV; Plange-Rhule J; Riesen W; Korte W; Luke A
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371950
[TBL] [Abstract][Full Text] [Related]
14. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
15. Maternal Factors Associated with Levels of Fatty Acids, Specifically n-3 PUFA during Pregnancy: ECLIPSES Study.
Aparicio E; Martín-Grau C; Bedmar C; Serrat Orus NS; Basora J; Arija V; The Eclipses Study Group
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499257
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
17. Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases.
Takic M; Pokimica B; Petrovic-Oggiano G; Popovic T
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889342
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
19. Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition.
Troesch B; Eggersdorfer M; Laviano A; Rolland Y; Smith AD; Warnke I; Weimann A; Calder PC
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32846900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
